Biotech and Pharmaceuticals
We’re cutting our price target on Danaher as frustration mounts after a messy quarter
Danaher shares are under pressure Wednesday as the Club holding’s fourth-quarter earnings results came in mixed and guidance disappointed. The company long known for its operational excellence is further testing our patience. Revenue for the three months ended Dec. 31 advanced 2% year over year on a reported basis, to $6.54 billion, outpacing the LSEG […]
Read More
Watch live: RFK Jr. testifies at Senate confirmation hearing for HHS secretary
[The stream is slated to start at 10 a.m. ET. Please refresh the page if you do not see a player above at that time.] Robert F. Kennedy, President Donald Trump’s controversial pick to lead the Department of Health and Human Services, is testifying on Wednesday before a Senate panel that is crucial to advance […]
Read More
Healthy Returns: Trump made sweeping changes to health care in his first week
U.S. President Donald Trump attends a House Republican members conference meeting in Trump National Doral resort, in Miami, Florida, U.S. Jan. 27, 2025. Elizabeth Frantz | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. […]
Read More
FDA approves Novo Nordisk’s Ozempic to treat chronic kidney disease in those with diabetes, expanding its use
The Food and Drug Administration on Tuesday approved Novo Nordisk‘s Ozempic to treat chronic kidney disease in patients who also have Type 2 diabetes, expanding the use of the wildly popular injection in the U.S. The drug is already widely used and covered to treat Type 2 diabetes. The FDA’s decision means Ozempic can now […]
Read More
Pharma is hopeful about Trump’s second term — here’s what to expect for drugmakers
U.S. President Donald Trump speaks about prescription drug prices during an appearance in the Brady Press Briefing Room at the White House in Washington, U.S., November 20, 2020. Carlos Barria | Reuters Pharmaceutical companies appear to be hopeful about their growth under a Trump administration, after former President Joe Biden took a hardline stance on […]
Read More
Strategas sees health care outperforming in 2025
The health care sector is poised to see a rebound and lead the market this year, according to Strategas analysts, in part because some of the biggest players in the market have been beaten down by regulatory concerns over the last two years. “Health care’s weight in the S & P is at its lowest […]
Read More
Novo Nordisk shares pop 10% on early-stage weight loss drug trial results
A view of the logo of Novo Nordisk at the company’s office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024. Tom Little | Reuters Shares of Novo Nordisk jumped Friday after the Danish pharmaceutical giant reported positive early-stage results for its once weekly amycretin obesity drug. The trial showed average weight reduction […]
Read More
UnitedHealthcare taps company veteran Tim Noel as new CEO following Brian Thompson killing
UnitedHealthcare (UHC) health insurance company signage is displayed on an office building in Phoenix, Arizona on July 19, 2023. Patrick T. Fallon | Afp | Getty Images UnitedHealthcare on Thursday tapped company veteran Tim Noel as its new CEO following the targeted killing of its former top executive, Brian Thompson, in Manhattan in December. Noel […]
Read More
A norovirus vaccine could be on the horizon as cases rise
A researcher works in the lab at the Moderna Inc. headquarters in Cambridge, Massachusetts, US, on Tuesday, March 26, 2024. Adam Glanzman | Bloomberg | Getty Images Norovirus is raging across the U.S. this winter. Moderna might soon have a vaccine for it. A large phase three trial of the shot is underway, with results […]
Read More
Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?
The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) on Dec. 5th, 2023. NYSE Group A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. I’m back in New York City after spending nearly a […]
Read More